Skip to main content

Prostaglandins and Inflammatory Hyperalgesia

  • Chapter
The Prostaglandin System

Part of the book series: NATO Advanced Study Institutes Series ((ASIAS))

Abstract

In our “Discussion on the mode of action of anti-inflammatory drugs” (in this book) it is pointed out that the therapeutic effects of aspirin-like drugs are symptomatic. These drugs do not interfere with the evolution of the chronic processes but act on the expression of some inflammatory signs and symptoms. Possibly, most of the therapeutic use of aspirin-like drugs in many diseases is due to their antialgic effect rather than to their anti-oedematogenic properties. If one day, we have drugs which really interfere with the progression of chronic diseases, aspirin-like drugs, i.e. cyclo-oxygenase inhibitors, will be classified as pseudo-anti-inflammatory drugs.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. V. A. Alabaster and Y. S. Bakhle. Release of smooth muscle-contracting substances from isolated perfused lungs. Europ. J. Pharmac., 35: 349–360 (1976).

    Article  CAS  Google Scholar 

  2. C. R. Beddell, R. L. Follenfant, L. A. Lowe, F. B. Ubatuba, S. Wilkinson and R. J. Miller. Analogues of the enkephalins -Structural requirements for opioid activity. In: “Biological Activity and Chemical Structure”. J. A. Keverling Buisman, ed., Elvesier Scientific Publishing Company, New York, pp. 177–193 (1977).

    Google Scholar 

  3. W. C. Chang, S. Murota and S. Tsurufugi. A new prostaglandin transformed from arachidonic acid in carrageenin-induced granuloma. Biochem. Biophys. Res. Comm., 72: 1259–1264 (1976).

    Article  PubMed  CAS  Google Scholar 

  4. M. L. Cohn, M. Cohn and F. H. Taylor. Guanosine 3’, 5’ monophosphate: A central nervous system regulator of analgesia. Science, 199: 319–322 (1978).

    Article  PubMed  CAS  Google Scholar 

  5. H. O. Collier and A. C. Roy. Inhibition of E- rostaglandins sensitive adenyl cyclase as the mechanism of morphine analgesia. Prostaglandins, 7: 361–376 (1974).

    PubMed  CAS  Google Scholar 

  6. A. Dembiska-Kiec, A. Zmuda and J. Krupinska. Inhibition of prostaglandin synthetase by aspirin-like drugs in different microsomal preparations. In: “Advances in Prostaglandins and Thromboxane Research”, vol. 1. B. Samuelsson and R. Paoletti, eds., Raven Press, New York, pp. 99–103 (1976).

    Google Scholar 

  7. J. C. Eccles and P. L. Mcgeer. Ionotropic and metabotropic transmission. Trends in Neurosciences, 2: 39–40 (1979).

    Article  Google Scholar 

  8. J. Faires and D. J. McCarty. Acute arthritis in man and dog after intrasynovial injection of sodium urate crystals. Lancet, 11: 682–685 (1962).

    Article  Google Scholar 

  9. S. Ferri, A. Santagostino, P. C. Braga and I. Galatelas. Decrease antinociceptive effect of morphine in rats treated intraventricularly with prostaglandin El. Psychopharmacologia (Berl.), 39: 231–235 (1974).

    Article  CAS  Google Scholar 

  10. S. H. Ferreira. Prostaglandins, aspirin-like drugs and analgesia. Nature, New Biol., 240: 200–203 (1972).

    Article  CAS  Google Scholar 

  11. S. H. Ferreira and M. Nakamura. Prostaglandin hiperalgesia: I, A cAMP/Ca2 dependent process; II, The peripheral analgesic activity of morphine, enkephalins and opioid antagonists; III, Relevance of the peripheral effect for the analgesic action of opioid antagonists. Prostaglandins, in press (1979).

    Google Scholar 

  12. S. H. Ferreira and J. R. Vane. Mode of action of anti-inflammatory agents which are prostaglandin synthetase inhibitors. In: “Anti-Inflammatory Drugs”, J. R. Vane and S. H. Ferreira, eds., Handbook of Experimental Pharmacology, vol. 50/II - Springer Verlag, Berlin, Heidelberg, pp. 348–398 (1978).

    Google Scholar 

  13. S. H. Ferriera, B. B. Lorenzetti and F. M. A. Correa. Central and peripheral antialgesic action of aspirin-like drugs. European J. Pharmacol., 53: 39–48 (1978).

    Article  Google Scholar 

  14. S. H. Ferreira, S. Moncada and J. R. Vane. Some effects of inhibiting endogenous prostaglandin formation on the responses of the cat spleen. Br. J. Pharmac., 47: 48–58 (1973).

    Article  CAS  Google Scholar 

  15. S. H. Ferreira, S. Moncada and J.R. Vane. Prostaglandins and the mechanism of analgesia produced by aspirin-like drugs. Br. J. Pharmac., 49: 86–97 (1973).

    Article  CAS  Google Scholar 

  16. S. H. Ferreira, M. Nakamura and M. S. A. Castro. The hyperalgesic effects of prostacyclin and prostaglandin E2. Prostaglandins, 16: 31–37 (1978).

    PubMed  CAS  Google Scholar 

  17. R. J. Flower and J. R. Vane. Inhibition of prostaglandin synthetase in brain explains the anti-pyretic activity of paracetamol (4-acetamido - phenol). Nature, 240: 410–411 (1972).

    Article  PubMed  CAS  Google Scholar 

  18. N. D. Goldberg, M. K. Haddox, S. E. Nicol, D. B. Glass, C. H. Sanford, F. A. Kuehl Jr. and R. Estensen. Biologic regulation through opposing influences of cyclic GMP and cyclic AMP: The yin yang hypothesis. In: “Advances in Cyclic Nucleotides Research”, G. I. Drummond, P. Greengard and G. A. Robinson, eds. Raven Press, New York, vol. 5 pp. 307–330 (1975).

    Google Scholar 

  19. A. G. Herman and S. Moncada. Release of prostaglandins and incapacitation after injection of endotoxin in the knee joint of the dog. Br. J. Pharmac., 53: 465p (1975).

    Google Scholar 

  20. H. Juan and F. Lembeck. Action of peptides and other algesic agents on paravascular pain receptors on the isolated perfused rabbit ear. Naunym-Schmiedeberg`s Arch. Pharmac., 283: 151–164 (1974).

    CAS  Google Scholar 

  21. H. Juan and F. Lembeck. Inhibition of action of Eprostaglandins (PGs) on paravascular pain receptors. Naunym-Schmiedebergs Arch. Pharmac., 285: R36 (1974).

    Google Scholar 

  22. J. Knoll, S. Furst and S. Makleits. The pharmacology of N-substituted azido-morphines. Arch. Ínt. Pharmacodyn., 228: 268–292 (1977).

    PubMed  CAS  Google Scholar 

  23. L. Lasagna. The clinical pharmacology of analgesics and analgesic antagonists. In: “Proc. of the 3rd International Pharmacol. Meeting”, R. K. S. Lim, ed. Pergamon Press,Oxford, vol. 9: 113–120 (1968).

    Google Scholar 

  24. R. K. S. Lim, F. Guzman, D. W. Rodgers, K. Goto, G. Braun, G. D. Dickerson and R. J. Engle. Site of action of narcotic and non-narcotic analgesics determined by blocking bradykinin-evoked visceral pain. Arch. Int. Pharmacodyn., 152: 25–59 (1964).

    PubMed  CAS  Google Scholar 

  25. W. R. Martin. Opioids antagonists. Pharmacol. Reviews, 4: 463–521 (1967).

    Google Scholar 

  26. S. Moncada, S. H. Ferreira and J. R. Vane. Inhibition of prostaglandin biosynthesis as the mechanism of analgesia of aspirin-like drugs in the dog knee joint. Europ. J. Pharmacol., 31: 250–260 (1975).

    Article  CAS  Google Scholar 

  27. E. R. Perl. Sensitization of nociceptors and its relation to sensation. In: “Advances in Pain Research and Therapy”, J. J. Bonica and D. Albe-Fessard, eds., Raven Press, New York, vol. I, pp. 17–34 (1976).

    Google Scholar 

  28. L. 0. Randall and J. J. Selitto. A method for measurement of analgesic activity on inflammed tissue. Arch. Int. Pharmacodyn., 111: 409–419 (1957).

    Google Scholar 

  29. M. E. Rosenthale, A. Dervinis, J. Kassarich and S. Singer. Prostaglandins and anti-inflammatory drugs in the dog knee joint. J. Pharm.Pharmac., 24: 149–152 (1972).

    Article  CAS  Google Scholar 

  30. E. W. Sutherland, G. A. Robison and R. W. Butcher. Some aspects of the biological role of adenosine 3’, 5’monophosphate (Cyclic AMP). Circulation, 37: 279–306 (1968).

    Article  CAS  Google Scholar 

  31. J. W. Ward, M. Foxwell and W. H. Funderburk. The detection of analgesia produced by morphine antagonists in laboratory animals. Pharmacologist, 7: 163 (1965).

    Google Scholar 

  32. A. L. Willis and M. Cornelsen. Repeated injection of prostaglandin E2 in rat paw induced chronic swelling and marked decrease in pain threshold. Prostaglandins, 3: 353–357 (1973).

    PubMed  CAS  Google Scholar 

  33. C. A. Winter and L. Flataker. Reaction thresholds to pressure in edematous hindpaws of rats and responses to analgesic drugs. J. Pharmacol. Exp. Therapeutics, 150: 165–171 (1965).

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1981 Plenum Press, New York

About this chapter

Cite this chapter

Ferreira, S.H. (1981). Prostaglandins and Inflammatory Hyperalgesia. In: Berti, F., Velo, G.P. (eds) The Prostaglandin System. NATO Advanced Study Institutes Series. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-3896-3_11

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-3896-3_11

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4684-3898-7

  • Online ISBN: 978-1-4684-3896-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics